Thursday, 16 April, 2009 06:06 Written by admin
Scientists have found important genetic differences that significantly raise the risk of stroke, and they are found in millions of people.
The study is the first to identify common genetic variants influencing stroke risk in the United States and may lead to better treatments, they reported on Wednesday.
While other stroke-related genes have been discovered, none involved such a wide portion of the population, said Eric Boerwinkle of The University of Texas Health Science Center.
Sunday, 15 February, 2009 06:12 Written by admin
Short of living in a bubble, there are no cures for allergies.
Even with shots and medicines, patients living with allergies still experience flare-ups and symptoms, especially if their allergies are seasonal.
Dr. Clifford Bassett, an assistant clinical professor of medicine at Long Island College Hospital, offered these seven tips, which may alleviate the severity of allergy symptoms, making it a little easier for allergy sufferers to enjoy life.
Monday, 12 January, 2009 07:00 Written by admin
Warfarin is an anticoagulant — or “blood thinner” — that’s frequently prescribed for people with atrial fibrillation.
An estimated 2.2 million Americans have the cardiac condition, which causes the heart’s two upper chambers to flutter, rather than beat efficiently. This leaves people vulnerable to a blood clot in the brain that can result in an ischemic stroke, the most common type of stroke.
That’s where warfarin comes in — helping to prevent those clots.
But, ironically, as use of warfarin has risen in recent years, so has the number of another type of stroke called hemorrhagic stroke, which occurs when a blood vessel ruptures in the brain.
Saturday, 13 December, 2008 21:30 Written by admin
GlaxoSmithKline Plc’s (GSK.L: Quote, Profile, Research, Stock Buzz) widely prescribed drug Advair is safe enough for treating asthma but two lesser-used medicines are too risky, a U.S. advisory panel ruled on Thursday.
Evidence of asthma-related deaths and serious complications led the panel of experts to warn against continued use of Glaxo’s Serevent and Novartis AG’s (NOVN.VX: Quote, Profile, Research, Stock Buzz) Foradil for adults, adolescents and children with asthma.